Skip to content

Clinical study of endoscopic retrograde cholangiopancreatography in endoscopic removal of gallbladder polyps through the duodenal pap

Clinical study of endoscopic retrograde cholangiopancreatography in endoscopic removal of gallbladder polyps through the duodenal pap

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500105155
Enrollment
Unknown
Registered
2025-06-30
Start date
2025-06-30
Completion date
Unknown
Last updated
2025-07-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gallbladder polyp

Interventions

Experimental group:A super-minimally invasive intervention therapy method for the treatment of gallbladder polyps through ERCP combined with endoscopic direct vision of the biliary and pancic ducts vi

Sponsors

Zhongda Hospital Affiliated to Southeast University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Research objects The following conditions should be met, 1) To be treated in the hospitals participating in this project; 2) Preoperative clinical considered: biliary tract diseases (such as intrahepatic and extrahepatic bile duct stones, common bile duct stones, obstructive jaundice, etc) combined with gallbladder polyps. 2. Inclusion criteria 1) Preoperative definite biliary tract disease combined with gallbladder polyps: biliary tract diseases common bile duct stones, intrahepatic and extrahepatic bile duct stones, benign tumors at the end of the common bile duct, obstructive jaund caused by polyps, etc. 2) There are contraindications to surgical operation; 3) Ages between 18 and 75, gender is not limited and there is no severe underlying disease. 4) Informed consent, willing to accept oral choledochoscopy treatment.

Exclusion criteria

Exclusion criteria: 1) Patients who do not meet the diagnostic criteria and inclusion criteria; 2) Those with contraindications to ERCP; 3) Patients with known malignant tumors of the biliary system; 4) Patients who cannot tolerate the ERCP procedure or cooperate, and are prone to loss to follow-up; 5) with severe cardiopulmonary insufficiency, hepatic and renal dysfunction, coagulation dysfunction, psychiatric disorders, etc.

Design outcomes

Primary

MeasureTime frame
Technical success rate;Clinical success rate;

Secondary

MeasureTime frame
General information;ERCP operation time;Endoscopic retrograde cholangiopancreatography procedure time;Resume meal time;Length of hospital stay;Postoperative abdominal pain rate;Complication occurrence: bleeding, perforation, pancreatitis, cardiovascular and cerebrovascular accidents, infection, etc.;Intermediate surgery; rate of surgery within a short period after surgery;

Countries

China

Contacts

Public ContactRuihua Shi

Department of Gastroenterology,Zhongda Hospital Affiliated to Southeast University,Nanjing,Jiangsu,China

ruihuashi@126.com+86 139 5179 9326

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026